PHILIPS INDIA LIMITED

GE HealthCare has acquired brain analysis company Icometrix for an undisclosed sum to expand its Alzheimer's disease diagnostic capabilities.

The FDA has granted 510(k) clearance to an updated version of the Philips UroNav System, featuring advanced annotation workflow for enhanced precision in minimally invasive prostate cancer focal therapy procedures.

Philips has received FDA 510(k) clearance for SmartSpeed Precise, an AI-powered MRI reconstruction tool that can scan up to three times faster while producing images up to 80% sharper than earlier methods.

Philips and Polarean have advanced their strategic partnership to bring radiation-free Xenon MRI technology to children with obstructive lung diseases, potentially extending access to patients as young as six years old pending FDA approval.

The DEFINE GPS trial has completed enrollment, evaluating iFR co-registration technology to improve precision in percutaneous coronary interventions (PCI) and reduce residual ischemia.

Philips has recalled its Tack Endovascular System following 20 reported injuries, with the FDA classifying it as a Class I recall due to serious safety concerns.

Spanish AI company Quibim has raised $50 million in Series A funding to expand its AI-powered medical imaging biomarker platform for disease diagnosis and research applications.

Paige has received FDA Breakthrough Device designation for PanCancer Detect, the first AI application designed to identify cancer across multiple tissue types and organs, addressing the growing pathology workforce shortage.

Philips secures FDA 510(k) clearance for its Radiology Operations Command Center (ROCC), enhancing remote scanning and protocol management capabilities.

Insightec's Exablate Prime system has gained FDA approval and CE mark for integration with select Philips MRI systems, expanding access to non-invasive treatments.